Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p

Abstract Bladder cancer (BC) is one of the most common malignant tumors of the urinary system, and cisplatin (CDDP) is a critical chemical drug for the treatment of BC. However, CDDP-resistance seriously limits the therapeutic efficacy of this drug for clinical utilization. Thus, identification of p...

Full description

Bibliographic Details
Main Authors: Ming Sun, Xuefeng Liu, Wenyan Zhao, Bin Zhang, Peng Deng
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-022-09419-1